Your session is about to expire
← Back to Search
Virtual Intensive Outpatient Program for Alcoholism
N/A
Recruiting
Led By Matthew Sloan, MD
Research Sponsored by Centre for Addiction and Mental Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Able to communicate and provide informed consent in English
≥ 18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days
Awards & highlights
Study Summary
This trial aims to offer a virtual intensive outpatient program for people with alcohol use disorder to help them reduce their drinking and improve their health.
Who is the study for?
This trial is for English-speaking adults over 18 with moderate to severe alcohol use disorder who are motivated to abstain from alcohol. Participants must attend daily virtual sessions on weekdays and take multiple breathalyzer readings each day. They need private space and OHIP coverage but can't join if they have a history of severe withdrawal, certain medical or psychiatric conditions, concurrent substance use disorders, or plans to be out of the province.Check my eligibility
What is being tested?
The study tests a 4-week virtual intensive outpatient program designed to help people with alcohol use disorder stop drinking. It includes group and individual therapy sessions conducted online, aiming to mimic residential treatment programs' structure and monitoring while participants remain at home.See study design
What are the potential side effects?
Since this is a behavioral intervention focusing on abstinence through virtual therapy rather than medication, typical drug side effects are not expected. However, participants may experience stress or emotional discomfort related to discussions during therapy sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can speak and understand English well enough to give informed consent.
Select...
I am 18 years old or older.
Select...
I can attend all sessions and do daily breathalyzer tests for the program.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 28 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Retention in treatment
Satisfaction with treatment as assessed by the Client Satisfaction Questionnaire-8 (CSQ-8)
Secondary outcome measures
Change in Anxiety Symptoms during the IOP Assessed Using the Generalized Anxiety Disorder-7 (GAD-7)
Change in Depressive Symptoms during the IOP Assessed Using the Patient Health Questionnaire-9 (PHQ-9)
Change in Emotion Regulation During the IOP Assessed Using the Difficulties in Emotion Regulation Scale (DERS)
+8 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Virtual Intensive Outpatient ProgramExperimental Treatment1 Intervention
Participants will be treated in a 4 week program involving daily psychotherapy groups, weekly individual therapy and medication management, as well as daily breathalyzer monitoring.
Find a Location
Who is running the clinical trial?
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,336 Previous Clinical Trials
25,751,045 Total Patients Enrolled
5 Trials studying Alcoholism
780 Patients Enrolled for Alcoholism
Centre for Addiction and Mental HealthLead Sponsor
351 Previous Clinical Trials
80,753 Total Patients Enrolled
16 Trials studying Alcoholism
3,442 Patients Enrolled for Alcoholism
Matthew Sloan, MDPrincipal InvestigatorCentre for Addiction and Mental Health
1 Previous Clinical Trials
400 Total Patients Enrolled
1 Trials studying Alcoholism
400 Patients Enrolled for Alcoholism
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can speak and understand English well enough to give informed consent.I have not consumed more than the defined risky amount of alcohol in the last 60 days.I am willing to avoid alcohol for a month during treatment.I do not have severe health or mental health issues that would make it unsafe for me to join the study.I am 18 years old or older.I can attend all sessions and do daily breathalyzer tests for the program.
Research Study Groups:
This trial has the following groups:- Group 1: Virtual Intensive Outpatient Program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research initiative currently open to participants?
"Clinicaltrials.gov states that this research endeavor is presently recruiting participants, having initially been posted on January 30th 2023 and recently revised as of February 1st 2023."
Answered by AI
How many individuals are currently undergoing this clinical research?
"Affirmative. According to the information shared on clinicaltrials.gov, recruitment for this medical study is open and ongoing since its posting date of January 30th 2023. It requires 63 participants from a single site and has most recently been updated on February 1st 2023."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger